86 related articles for article (PubMed ID: 12960234)
1. HIV-1 fitness and macrophages.
Goodenow MM; Rose SL; Tuttle DL; Sleasman JW
J Leukoc Biol; 2003 Nov; 74(5):657-66. PubMed ID: 12960234
[TBL] [Abstract][Full Text] [Related]
2. Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome.
Gray L; Sterjovski J; Churchill M; Ellery P; Nasr N; Lewin SR; Crowe SM; Wesselingh SL; Cunningham AL; Gorry PR
Virology; 2005 Jul; 337(2):384-98. PubMed ID: 15916792
[TBL] [Abstract][Full Text] [Related]
3. Viral and host cofactors facilitate HIV-1 replication in macrophages.
Wahl SM; Greenwell-Wild T; Peng G; Ma G; Orenstein JM; Vazquez N
J Leukoc Biol; 2003 Nov; 74(5):726-35. PubMed ID: 12960226
[TBL] [Abstract][Full Text] [Related]
4. Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression.
Magnani M; Balestra E; Fraternale A; Aquaro S; Paiardini M; Cervasi B; Casabianca A; Garaci E; Perno CF
J Leukoc Biol; 2003 Nov; 74(5):764-71. PubMed ID: 12960277
[TBL] [Abstract][Full Text] [Related]
5. Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle.
Giguère JF; Bounou S; Paquette JS; Madrenas J; Tremblay MJ
J Virol; 2004 Jun; 78(12):6222-32. PubMed ID: 15163715
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.
Martinez-Picado J; Martínez MA
Virus Res; 2008 Jun; 134(1-2):104-23. PubMed ID: 18289713
[TBL] [Abstract][Full Text] [Related]
7. HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus.
Brown A; Gartner S; Kawano T; Benoit N; Cheng-Mayer C
J Leukoc Biol; 2005 Sep; 78(3):675-85. PubMed ID: 16000390
[TBL] [Abstract][Full Text] [Related]
8. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V;
J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728
[TBL] [Abstract][Full Text] [Related]
9. Macrophages and HIV-1: dangerous liaisons.
Verani A; Gras G; Pancino G
Mol Immunol; 2005 Feb; 42(2):195-212. PubMed ID: 15488608
[TBL] [Abstract][Full Text] [Related]
10. Monocyte/macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: a complex network of interactions influencing viral replication and AIDS pathogenesis.
Fantuzzi L; Belardelli F; Gessani S
J Leukoc Biol; 2003 Nov; 74(5):719-25. PubMed ID: 12960239
[TBL] [Abstract][Full Text] [Related]
11. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
Azevedo-Pereira JM; Santos-Costa Q
Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
[TBL] [Abstract][Full Text] [Related]
12. Macrophage activation and human immunodeficiency virus infection: HIV replication directs macrophages towards a pro-inflammatory phenotype while previous activation modulates macrophage susceptibility to infection and viral production.
Porcheray F; Samah B; Léone C; Dereuddre-Bosquet N; Gras G
Virology; 2006 May; 349(1):112-20. PubMed ID: 16564558
[TBL] [Abstract][Full Text] [Related]
13. The host environment drives HIV-1 fitness.
van Opijnen T; Berkhout B
Rev Med Virol; 2005; 15(4):219-33. PubMed ID: 15942979
[TBL] [Abstract][Full Text] [Related]
14. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1.
Joly M; Pinto JM
Math Biosci; 2005 May; 195(1):92-126. PubMed ID: 15893340
[TBL] [Abstract][Full Text] [Related]
15. Determination of cell tropism of HIV-1.
Kootstra NA; Schuitemaker H
Methods Mol Biol; 2005; 304():317-25. PubMed ID: 16061985
[TBL] [Abstract][Full Text] [Related]
16. HIV type 1 fitness evolution in antiretroviral-experienced patients with sustained CD4+ T cell counts but persistent virologic failure.
Prado JG; Parkin NT; Clotet B; Ruiz L; Martinez-Picado J
Clin Infect Dis; 2005 Sep; 41(5):729-37. PubMed ID: 16080097
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic strategies towards HIV-1 infection in macrophages.
Perno CF; Svicher V; Schols D; Pollicita M; Balzarini J; Aquaro S
Antiviral Res; 2006 Sep; 71(2-3):293-300. PubMed ID: 16806514
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 dynamics in vivo: implications for therapy.
Simon V; Ho DD
Nat Rev Microbiol; 2003 Dec; 1(3):181-90. PubMed ID: 15035022
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies.
Aquaro S; Svicher V; Schols D; Pollicita M; Antinori A; Balzarini J; Perno CF
J Leukoc Biol; 2006 Nov; 80(5):1103-10. PubMed ID: 16931601
[TBL] [Abstract][Full Text] [Related]
20. Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages.
Mikulak J; Gianolini M; Versmisse P; Pancino G; Lusso P; Verani A
Virology; 2009 Jul; 390(1):37-44. PubMed ID: 19447459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
